腹腔镜肝部分切除术治疗肝癌患者血清肿瘤标志物的变化

doi:10.3969/j.issn.1672-5069.2018.01.032

Abstract

Sun Qifeng, Zhao Zhiqiang, Zhou Tong, et al. Serum tumor marker changes after laparoscopic partial hepatectomy in patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 121-122.

References

[1] 陈威,易永祥,张海斌,等. 3种评分系统预测肝移植短期预后的效果评价. 中华肝胆外科杂志,2014,20（8）: 557-561.
[2] 冯钜涛,陈劲松,岑钧华,等. 腹腔镜肝切除术治疗肝癌的疗效观察.中国现代医生,2013,51（17）:157-158.
[3] 田贵金,刘军红,刘涛,等. 白介素2联合胸腺肽α1对肝癌术后患者肝纤维化指标和肝功能的影响. 现代医学,2016,44（1）: 68-71.
[4] 高洪元. 原发性肝癌患者炎性细胞因子检测的临床诊断价值. 实用检验医师杂志,2015,7（2）:86-89.
[5] 蒋亚琦. 腹腔镜下肝切除术患者围术期纤维化及氧代谢指标的变化. 海南医学院学报,2016,22（8）:784-786.
[6] Abu HM,Di FF,Abu S M,et al. Oncological efficiency analysis of laparoscopic liver resection for primary and metastatic cancer: a single-center UK experience. Arch Surg,2012,147（1）:42-48.
[7] 中华人民共和国卫生部. 原发性肝癌诊疗规范（2011年版）. 中华肝脏病杂志,2012,20（6）:929-946.
[8] 吴振宇,胡浩,金昌国,等. 不同入路腹腔镜肝切除术29例临床应用. 中国内镜杂志,2015,21（6）:657-660.
[9] Alkhalili E,Berber E. Laparoscopic liver resection for malignancy:a review of the literature. World J Gastroenterol,2014,20（37）:13599-13606.
[10] 易永祥,王建,王翔,等. 腹腔镜与开腹左外叶切除术对患者临床康复和机体免疫功能的影响. 中国老年学杂志,2015,12（35）:6844-6846.
[11] 葛勇胜,荚卫东,许戈良,等. 腹腔镜下肝叶切除术14例报告. 实用肝脏病杂志,2015,18（2）：128-131.
[12] 李社方,陈伟荣,明涛. 腹腔镜肝部分切除术对肝癌患者肿瘤标志物及纤维化、炎性指标的影响研究. 腹腔镜外科杂志,2015,20（5）:324-327.
[13] 常啸,李家斌. 川芎嗪联合干扰素γ治疗慢性乙肝患者对肝纤维化进程的影响. 海南医学院学报,2016,22（24）:2999-3002.
[14] 詹剑锋,宋茂舟,林镜宏,等. 干扰素联合胸腺肽α1序贯治疗耐核苷类药物乙肝肝硬化患者病毒复制及肝纤维化的影响. 海南医学院学报,2016,22（17）:1950-1953.
[15] Okanoue T,Mizuno M. Liver function tests and liver injury - focusing on AST/ALT and PLT count. Jap J Mhts,2015,42（2）:307-312.
[16] 王兆雄,武星君. 腹腔镜肝癌切除术患者围术期炎性介质及纤维化指标的变化. 实用临床医药杂志,2016,20（15）:170-171.

Serum tumor marker changes after laparoscopic partial hepatectomy in patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[2]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[3]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[4]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[5]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[6]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[7]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[8]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[9]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[10]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[11]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[12]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[13]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.
[14]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.
[15]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.